Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program
2 Federal Government Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
3 Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
4 Johnson & Johnson Secures $1B in Federal Vaccine Production Funding
5 Other news to note for Aug. 6, 2020 | 2020-08-06
6 Just
7 Partner Therapeutics Announces $35 Million Contract with US Department of Defense for Advanced Development and Emergency Use of Leukine® (rhuGM-CSF) for COVID-19 Acute Hypoxemic Respiratory Failure (AHRF)
8 Sanofi, GlaxoSmithKline make coronavirus vaccine deal with U.S.
9 Johns Hopkins researchers get $35M grant to test COVID-19 outpatient treatment
10 Johns Hopkins Receives $35 Million in Funding from Department of Defense for Covid-19 Blood Plasma Trials
11 US Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine
12 HHS, DoD Sign $2B Coronavirus Vaccine Deal With Pfizer-BioNTech Partnership
13 BARDA and JPEO-CBRND strike two partnerships to expand domestic manufacturing for needles, syringes
14 Smiths Medical Partners With U.S. Government on COVID-19 Vaccine Efforts
15 Sanofi, GSK Pursue COVID-19 Vaccine Trials with $2.1B from "Warp Speed"
16 Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent's COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
17 Keene medical device facility's parent company wins big vaccine-related contract
18 SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-176 for Seasonal Influenza | Antibodies | News Channels
19 U.S. Army prepares for nerve agent attacks
20 HHS, DoD Award $2.05B in COVID-19 Vaccine, Treatment Production Contracts; Alex Azar Quoted
21 Emergent BioSolutions and partners to develop Covid-19 therapy
22 SAB Biotherapeutics Closes Series B Funding
23 U.S. Army Awards $21.8M Production Contract to FLIR Systems for Nerve Agent Disclosure Spray
24 Former U.S. government contractor head accused of stealing taxpayer funds to fuel no-show job for girlfriend,
25 Federal agencies collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses
26 Smiths Medical lands major vaccine-related contract | Medical Design and Outsourcing
27 INOVIO to Report Second Quarter 2020 Financial Results on August 10, 2020
28 Regeneron's New COVID-19 Treatment Could be Ready By End of Summer
29 DC-Based Startup Public Spend Forum Awarded Phase II SBIR to Expand Supplier Intelligence Platform to Meet USAF, DOD Emerging Technology Needs
30 Other news to note for Aug. 4, 2020 | 2020-08-04
31 BD sells 750K antigen tests to HHS as COVID-19 nursing home testing scales up
32 Urgent Acquisition Effort Provides Safe COVID-19 Patient Transport in 95 Days
33 INOVIO Receives Orphan Drug Designation From US FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)
34 BD Receives Orders for 177 Million Injection Devices in Anticipation of COVID-19 Vaccine Approval
35 INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
36 US Army awards contract to FLIR Systems for Nerve Agent Disclosure Spray | Defense News July 2020 Global Security army industry | Defense Security global news industry army 2020 | Archive News year
37 JPEO-CBRND Works with Industry to Develop COVID-19 Diagnostic Tests
38 July 22 coronavirus news
39 BD Receives Additional Orders For 177 Million Injection Devices For US, Canada COVID-19 Vaccine Preparations
40 Just Enough: What Amounts to Success for a Synthetic Opioid Antidote
41 Chem-Bio Defense Office Reorganizes to Take on New Threats
42 Coronavirus Test Maker Hits A New High
43 DOD OTA AGREEMENT LEVERAGED BY INTERAGENCY FOR COVID-19 RAPID RESPONSE
44 SAB Biotherapeutics Raises $14M in Series B Funding
45 U.S. Government Issues RFI for Solutions to Combat Coronavirus (COVID-19)
46 Other news to note for July 15, 2020 | 2020-07-15
47 DOD LEVERAGING DIAGNOSTIC PLATFORM FOR COVID-19 RAPID RESPONSE
48 Emergent lands $20M contract to develop chemical weapon antidote
49 PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
50 Global CBRN Market Analysis & Technologies, 2020-2028
51 MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense
52 Militarizing Global Health Isn't the Right Answer
53 Department of Defense Awards Ology Bioservices Contract to Advance Anti-Botulinum Neurotoxin Monoclonal Antibodies
54 Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense
55 Coronavirus Pandemic Solutions Sought by Government
56 Kansas City's MRIGlobal Wins $2 Million Defense Contract For Mobile Lab COVID-19 Testing
57 Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
58 The Heavy Cost of Ignoring Biosurveillance
59 Efforts to counter WMD threats complicated by data challenges
60 Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
61 Kratos Mobile Laboratory Product Supporting COVID-19 Response Efforts
62 Department of the Army, the Surgeon General-Sponsored Assay Supports First-Ever FDA-Approved Ebola Vaccine in U.S.
63 A Comprehensive COVID-19 Vaccine Plan
64 AFLCMC led team delivers isolation container prototype for testing
65 Alion to Support U.S. Chemical, Biological, and Nuclear Defense
66 SIGA Technologies Announces Department of Defense Increases Funding to Develop Post-Exposure Prophylactic Indication for TPOXX®
67 DTRA engages partners, industry at CWMD conference
68 Collaboration Made NBCRV's Sensor Suite Upgrade Possible
69 SiO2 Materials Science Receives $143 Million Contract from U.S. Government to Accelerate Capacity Scale-Up of Advanced Primary Packaging Platform for COVID-19 Vaccines and Therapeutics
70 Ology Bioservices Gets $42.6M DoD Contract
71 Equine Encephalitis Virus Vaccine Shows Positive Study Results
72 Ology Bioservices Inks $27M DoD Deal
73 Defense Officials See Increased Threat from Chinese Russian ChemBio Weapon
74 Defense Dept. to Use mHealth Wearables to Test COVID-19 Treatments
75 DoD Taps Local Company for COVID-19 Assistance
76 Chem-Bio Defense Program Eases Path for Industry
77 U.S. Departments of Defense, Health & Human Services select Corning Valor® Glass packaging to accelerate delivery of COVID-19 vaccines
78 Ology Bioservices to Adapt Veroplex® Cell Platform for Rapid Response to Viral Threats for Department of Defense
79 NPC, NPC-L ready to save lives > Team McChord > Article Display
80 Regeneron Announces Manufacturing and Supply Agreement for BARDA and US Department of Defense for REGN-COV2 Anti-Viral Antibody Cocktail
81 Q&A released with JPEO-CBRND, US Army ahead of SMi's Future Armoured Vehicles Survivability 2019
82 JPEO-CBD Activates New Joint Project Management Office of Medical Countermeasure Systems (MCS)
83 Lawmakers have questions about removal of State Department IG
84 Negatively pressurized conexes ready to save lives
85 DTRA contributes to historic Ebola vaccine effort
86 Colin Powell Still Wants Answers
87 Auburn company scores $143M contract to aid Covid-19 vaccine efforts
88 SAB wins contract to develop rapid response antibody for US DOD
89 SAB Biotherapeutics Advances Therapeutic for COVID-19 in Partnership with Department of Defense and BARDA
90 Army Scientist Plays Key Role in International Ban on Nerve Agent
91 News
92 WMD management complicated by data challenges
93 JUPITR program takes shape on Korean Peninsula
94 Latest sensor upgrades boost recon vehicle capabilities
95 News
96 HHS, DoD provide advanced development support for Cepheid's COVID-1- rapid diagnostic
97 SAB and DoD advance therapeutic drug candidate for Covid-19
98 INOVIO Receives $71 Million Contract From US Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA Vaccine
99 Air Force Fields Next Generation CBRN Protective Masks for Rotary Wing Aircrew
100 VIEWPOINT: The Tools and Threats of Synthetic Bioweapon Development